Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    SQZ Biotechnologies

    NYSE: SQZ · Real-Time Price · USD
    0.43
    0.16 (59.26%)
    At close: Jul 03, 2023, 5:00 PM

    SQZ Biotechnologies Statistics

    Share Statistics

    SQZ Biotechnologies has 29.49M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 29.49M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 22,357

    FTD / Avg. Volume

    n/a
    		 4.04%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -0.27 and the forward PE ratio is null. SQZ Biotechnologies's PEG ratio is -0.03.

    PE Ratio

    n/a
    		 -0.27

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 1.01

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.37

    P/FCF Ratio

    n/a
    		 -0.25

    PEG Ratio

    n/a
    		 -0.03
    Financial Ratio History

    Enterprise Valuation

    SQZ Biotechnologies has an Enterprise Value (EV) of -14.92M.

    EV / Sales

    n/a
    		 -0.71

    EV / EBITDA

    n/a
    		 0.25

    EV / EBIT

    n/a
    		 0.18

    EV / FCF

    n/a
    		 0.18

    Financial Position

    The company has a current ratio of 3.12, with a Debt / Equity ratio of 0.48.

    Current Ratio

    n/a
    		 3.12

    Quick Ratio

    n/a
    		 3.14

    Debt / Equity

    n/a
    		 0.48

    Debt / EBITDA

    n/a
    		 -0.46

    Debt / FCF

    n/a
    		 -0.33

    Interest Coverage

    n/a
    		 -8.3

    Financial Efficiency

    Return on Equity is -136.91% and Return on Invested Capital is -93.89%.

    Return on Equity

    n/a
    		 -136.91%

    Return on Assets

    n/a
    		 -78.32%

    Return on Invested Capital

    n/a
    		 -93.89%

    Revenue Per Employee

    n/a
    		 $396,773.58

    Profits Per Employee

    n/a
    		 $-1,476,301.89

    Employee Count

    n/a
    		 53

    Asset Turnover

    n/a
    		 0.21

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -1.22M

    Effective Tax Rate

    n/a
    		 1.54%

    Stock Price Statistics

    The stock price has increased by 745.96% in the last 52 weeks. The beta is 2.71, so SQZ Biotechnologies's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.71

    52-Week Price Change

    n/a
    		 745.96%

    50-Day Moving Average

    n/a
    		 0.15

    200-Day Moving Average

    n/a
    		 0.68

    Relative Strength Index (RSI)

    n/a
    		 30.63

    Average Volume (20 Days)

    n/a
    		 553,611

    Income Statement

    In the last 12 months, SQZ Biotechnologies had revenue of 21.03M and earned -78.24M in profits. Earnings per share was -2.72.

    Revenue

    n/a
    		 21.03M

    Gross Profit

    n/a
    		 21.03M

    Operating Income

    n/a
    		 -80.68M

    Net Income

    n/a
    		 -78.24M

    EBITDA

    n/a
    		 -59.28M

    EBIT

    n/a
    		 -69.75M

    Earnings Per Share (EPS)

    n/a
    		 -2.72
    Full Income Statement

    Balance Sheet

    The company has 63.71M in cash and 27.47M in debt, giving a net cash position of 36.24M.

    Cash & Cash Equivalents

    n/a
    		 63.71M

    Total Debt

    n/a
    		 27.47M

    Net Cash

    n/a
    		 36.24M

    Retained Earnings

    n/a
    		 -274.97M

    Total Assets

    n/a
    		 29.79M

    Working Capital

    n/a
    		 3.25M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -83.55M and capital expenditures -522K, giving a free cash flow of -84.07M.

    Operating Cash Flow

    n/a
    		 -83.55M

    Capital Expenditures

    n/a
    		 -522K

    Free Cash Flow

    n/a
    		 -84.07M

    FCF Per Share

    n/a
    		 -2.92
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -383.68% and -372.08%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -383.68%

    Pretax Margin

    n/a
    		 -377.88%

    Profit Margin

    n/a
    		 -372.08%

    EBITDA Margin

    n/a
    		 -281.91%

    EBIT Margin

    n/a
    		 -383.68%

    FCF Margin

    n/a
    		 -399.79%

    Dividends & Yields

    SQZ does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -366.97%

    FCF Yield

    n/a
    		 -394.3%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for SQZ.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jul 7, 2023. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Jul 7, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -22.94

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist